Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lung Neoplasms 2 Agnosia 2 Pancreatic Neoplasms 1 Neuroma 1 Laparoscopic Surgery 1 Disease 1 Breast Neoplasms 1

Interventions

Magnetic Resonance Imaging 2 Cryosurgery 2 imetelstat 1 Waiting Lists 1 Transcutaneous Electric Nerve Stimulation 1 S-Adenosylmethionine 1 Prostatectomy 1 Pluvicto 1 Observation 1 Nivolumab 1 Mammography 1 High-Intensity Interval Training 1 Hematologic Tests 1 Fluorodeoxyglucose F18 1 Exercise 1 Equipment and Supplies 1 Educational Status 1 Diagnostic Techniques and Procedures 1 Diagnosis, Computer-Assisted 1 Bupivacaine 1 Blood Specimen Collection 1 Artificial Intelligence 1 Arginine 1 Acupressure 1 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 1 (225)Ac-PSMA-617 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Bupivacaine × 90 days × Clear all

NCT07254650 2026-05-28

CALMS-1

University of Texas Southwestern Medical Center

Phase NA Not yet recruiting

Agnosia, Disease, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡